Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Some of these include: Hypoglycemia (a blood sugar level thats too low) Allergic reactions Worsening of diabetic retinopathy (eye disease) Acute kidney injury Possible increased risk of pancreatic or thyroid cancer Interactions with other medications Because of the results of animal studies, there has been some concern that semaglutide, liraglutide, and other GLP-1 RAs might increase the risk of certain cancers, including thyroid cancer
For many patients, the answer will be yes the medication is bioequivalent, the injection device is comparable, and the cost savings are real
6 (17), e13852
There are some coupons available
Yet many patients are prescribed them with little discussion beyond body weight, nausea, constipation, and refill timing
